Transforming patient care through cell and gene therapy
Cell therapy advances highlighted during The ONE Forum 2020
6 Considerations When Evaluating Cell Sourcing Vendors
Including questions to ask potential cell sourcing partners
How CAR-T reimbursement discussions help advance the field
Proposed IPPS rule an encouraging step towards a clearer payment process
5 Qualities to Seek in Your Cell Therapy Supply Chain Vendor
Considerations to help lower your cell or gene therapy logistics risk
Overcoming autologous cell therapy logistics challenges in the age of COVID-19
Experienced team for managed logistics is key
Can cell therapies unlock the COVID-19 mystery?
The promise of MSC therapies to treat deadly manifestations of cytokine storms
How COVID-19 is changing the production of cell therapies
Implementation of contingency plans allows for continued progress in therapy development
Managing donor collections during the COVID-19 pandemic
Why a diverse apheresis center network is critical to business continuity
Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)
Why established systems and relationships matter